Fifth Third Bancorp
MIRM icon

Fifth Third Bancorp’s Mirum Pharmaceuticals MIRM Stock Holding History

Fifth Third Bancorp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.4K Sell
319
-282
-47% -$28.3K ﹤0.01% 3338
2026
Q1 		$55.6K Buy
+601
New +$56.5K ﹤0.01% 3151
2025
Q2 		– Sell
-263
Closed -$11.8K – 2615
2025
Q1 		$11.8K Buy
+263
New +$12.4K ﹤0.01% 1941

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fifth Third Bancorp's MIRM Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Mirum Pharmaceuticals (MIRM) stake by 47% in Q2 2026, selling an estimated $28.3K and leaving 319 shares worth $37.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3338.

Fifth Third Bancorp first reported a position in MIRM in Q1 2025 and has held it in 3 quarters since. The position peaked at $55.6K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Fifth Third Bancorp held 319 shares of Mirum Pharmaceuticals worth $37.4K as of Q2 2026.
  • Fifth Third Bancorp sold 282 Mirum Pharmaceuticals shares in Q2 2026, an estimated $28.3K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3338 holding.
  • Fifth Third Bancorp first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Fifth Third Bancorp's Mirum Pharmaceuticals position peaked at $55.6K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.